Search
for
Sort by
Research 181–210 of 205
- Alopecia areata
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Atopic diseases and the risk of alopecia areata among pre-teens and teenagers in Taiwan
- Systemic Therapies for Scarring and Non-scarring Alopecia
- Optimization and Characterization of TSG-Enriched Polygonum multiflorum Extract and Its Dual Mechanism Against Androgenetic Alopecia via 5α-Reductase Inhibition and Wnt/β-Catenin Activation
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Causal Link of Distinct Mental Disorders with Androgenetic Alopecia and Alopecia Areata: A Bidirectional Two-Sample Mendelian Randomization Study
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Alopecia areata exhibits cutaneous and systemic OX40 activation across atopic backgrounds
- New Treatment Options for Alopecia Areata
- Recent advances in the genetics of alopecia areata
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- A randomized placebo-controlled single-center pilot study of the safety and efficacy of apremilast in subjects with moderate-to-severe alopecia areata
- New developments in the molecular treatment of ichthyosis: review of the literature
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib Therapy
- Interdisciplinarity traditional Chinese medicine microneedles in skin disease treatment: Recent advances and challenges
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- Genetic links between atopy, allergy, and alopecia areata: insights from a Mendelian randomization study
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm
- New therapies for alopecia areata
- Follicular Atopic Dermatitis in Dark Skin
- “<i>Nomen Omen</i>: The Myth of God Janus”
- Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
- Features of sensitization in patients with alopecia areata, associated with atopic diseases
- Th22 is the effector cell of thymosin β15-induced hair regeneration in mice
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Detection of subtypes of T helper cells and their cytokines in peripheral blood of patients with systematic lupus erythematosus and their clinical significances
- 269 Down-regulatory role of cholecystokinin on psoriatic epidermal inflammation
- Major Differences in Expression of Inflammatory Pathways in Skin from Different Body Sites of Healthy Individuals